Bitte verwenden Sie diesen Link, um diese Publikation zu zitieren, oder auf sie als Internetquelle zu verweisen: https://hdl.handle.net/10419/24139 
Erscheinungsjahr: 
2005
Schriftenreihe/Nr.: 
ZEW Discussion Papers No. 05-47
Verlag: 
Zentrum für Europäische Wirtschaftsforschung (ZEW), Mannheim
Zusammenfassung: 
This paper considers the U.S. Small Business Innovation Research (SBIR) program as a policy fostering academic entrepreneurship. We highlight two main characteristics of the program that make it attractive as an entrepreneurship policy : early-stage financing and scientist involvement in commercialization. Using unique data on NIH supported biomedical researchers, we trace the incidence of biomedical entrepreneurship through SBIR and describe some of the characteristics of these individuals. To explore the importance of early-stage financing and scientist involvement, we complement our individual level data with information on scientist-linked and non-linked SBIR firms. Our results show that the SBIR program is being used as a commercialization channel by academic scientists. Moreover, we find that the firms associated with these scientists perform significantly better than other non-linked SBIR firms in terms of followon venture capital funding, SBIR program completion, and patenting.
Schlagwörter: 
Academic entrepreneurship
star scientists
SBIR
Venture Capital
innovation
JEL: 
C25
O38
O31
M13
G38
Dokumentart: 
Working Paper

Datei(en):
Datei
Größe
151.15 kB





Publikationen in EconStor sind urheberrechtlich geschützt.